The endocrine response to acute ghrelin administration is blunted in patients with anorexia nervosa, a ghrelin hypersecretory state
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Summary: objective Ghrelin, a gastric‐derived natural ligand of the GH secretagogue (GHS)‐receptor (GHS‐R), strongly stimulates GH secretion but also possesses other neuroendocrine actions, stimulates food intake and modulates the endocrine pancreas and energy homeostasis. Ghrelin secretion is negatively modulated by food intake. Similarly, glucose and also insulin probably exert an inhibitory effect on ghrelin secretion. Fasting ghrelin levels are reduced in obesity, elevated in anorexia nervosa and restored by weight recovery. The chronic elevation of circulating ghrelin levels in anorexia suggested the hypothesis of an alteration of the sensitivity to the orexigenic action of ghrelin in this condition. The aim of this study was to define the endocrine actions of ghrelin in patients with anorexia nervosa. design We enrolled nine women with anorexia nervosa of restricter type [AN; age (mean ± SEM) 24·2 ± 1·8 years; body mass index (BMI) 14·7 ± 0·4 kg/m 2] and seven normal young women in their early follicular phase as control group (NW; age 30·6 ± 3·1 years; BMI 20·3 ± 0·5 kg/m 2). measurements In all the subjects we studied the GH, PRL, ACTH, cortisol, insulin and glucose responses to acute ghrelin administration (1·0 µg/kg as i.v. bolus). The GH response to GHRH (1·0 µg/kg as i.v. bolus) and basal ghrelin and IGF‐I levels were also evaluated in all the subjects. results Basal morning ghrelin and GH levels in AN (643·6 ± 21·3 ng/l and 10·4 ± 0·5 µg/l, respectively) were higher (P < 0·05) than in NW (233·5 ± 14·2 ng/l and 0·7 ± 0·7 µg/l, respectively). However, IGF‐I levels in AN (145·3 ± 10·9 µg/l) were lower (P < 0·05) than in NW (325·4 ± 12·6 µg/l). The GH response to GHRH in AN was higher (P < 0·05) than that in NW, but in AN the GH response to ghrelin was lower (P < 0·05) than that in NW. In AN and NW ghrelin also induced similar increases (P < 0·05) in PRL, ACTH and cortisol levels. Ghrelin administration was followed by significant increase in glucose levels in NW (P < 0·05) but not in AN. conclusions This study demonstrates that anorexia nervosa, a clinical condition of ghrelin hypersecretion, shows a specific reduction in the GH response to ghrelin, despite the hyper‐responsiveness to GHRH administration. The impaired GH response to ghrelin in anorexia nervosa agrees with previous evidence of blunted GH response to synthetic GH secretagogues and could reflect desensitization of the GHS receptor induced by the chronic elevation of ghrelin levels in this pathological state.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR)
American Psychiatric Association (2000) · doi:10.1176/appi.books.9780890423349 · Cited by 11,069
Ghrelin induces adiposity in rodents
Tschöp, M., Smiley, D. L., & Heiman, M. L. (2000) · Nature · doi:10.1038/35038090 · Cited by 3,949
The Novel Hypothalamic Peptide Ghrelin Stimulates Food Intake and Growth Hormone Secretion
Wren, A. M., Small, C. J., Ward, H. L., Murphy, K. G., Dakin, C. L., Taheri, S., Kennedy, A. R., Roberts, G. H., Morgan, D. G. A., Ghatei, M. A., et al. (2000) · Endocrinology · doi:10.1210/endo.141.11.7873 · Cited by 1,593
Ghrelin Strongly Stimulates Growth Hormone Release in Humans
Takaya, K., Ariyasu, H., Kanamoto, N., Iwakura, H., Yoshimoto, A., Harada, M., Mori, K., Komatsu, Y., Usui, T., Shimatsu, A., et al. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.12.7167 · Cited by 864
Hataya, Y., Akamizu, T., Takaya, K., Kanamoto, N., Ariyasu, H., Saijo, M., Moriyama, K., Shimatsu, A., Kojima, M., Kangawa, K., et al. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.9.8002 · Cited by 293 · cited 2×
“, 2002) and that ghrelin and GHRH exert synergic effects on somatotroph secretion (Arvat et al., 2001; Hataya et al., 2001; Cunha & Mayo, 2002), an increased GH response to ghrelin could have been foreseen.”
Background
Cited by
Ghrelin increases food intake in obese as well as lean subjects
Druce, M. R., Wren, A. M., Park, A. J., Milton, J. E., Patterson, M., Frost, G., Ghatei, M. A., Small, C., & Bloom, S. R. (2005) · International Journal of Obesity · doi:10.1038/sj.ijo.0803001 · Cited by 397
Ghrelin in the regulation of body weight and metabolism
Castañeda, T. R., Tong, J., Datta, R., Culler, M., & Tschöp, M. H. (2010) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2009.10.008 · Cited by 352
Lanfranco, F., Bonelli, L., Baldi, M., Me, E., Broglio, F., & Ghigo, E. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0049 · Cited by 112
“Metabolic factors have a major impact on ghrelin secretion regulation, and the pathophysiological conditions mentioned above are not, by chance, associated with ghrelin hypersecretion (11, 15, 46).”
BackgroundSelf-citationStievenard, A., Méquinion, M., Andrews, Z. B., Destée, A., Chartier-Harlin, M.-C., Viltart, O., & Vanbesien-Mailliot, C. C. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.11.021 · Cited by 39
“Conversely, ike in control subjects, a sensation of hunger was shown in six ut of nine AN patients after a bolus intravenous injection of mg/kg ghrelin (Broglio et al., 2004a).”
BackgroundEndocrine and Metabolic Actions of Ghrelin
Gasco, V., Beccuti, G., Marotta, F., Benso, A., Granata, R., Broglio, F., & Ghigo, E. (2010) · Endocrine Development · doi:10.1159/000262531 · Cited by 30
Self-citation
Metadata
- Authors
- Broglio, F., Gianotti, L., Destefanis, S., Fassino, S., Abbate Daga, G., Mondelli, V., Lanfranco, F., Gottero, C., Gauna, C., Hofland, L., Van der Lely, A. J., & Ghigo, E.
- Venue
- Clinical Endocrinology
- Publisher
- Wiley
- Published
- 2004-03-16
- Volume
- 60
- Issue
- 5
- Pages
- 592-599
- ISSN
- 0300-0664 (ISSN-L)
- 1365-2265
- OpenAlex
- W2092709199
- Cited by
- 129
- References
- 5
- FWCI
- 2.75
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.